Discovery of Small Molecule Inhibitors for Histone Methyltransferases in Cancer
Cancer is the second leading cause of mortality in the United States. There are several therapeutic regimens employed to mitigate the mortality rate of cancer. This includes the use of chemotherapy, radiation, immunotherapy, and precision medicine/targeted therapy. Targeted therapy involves the use...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/72479 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Discovery of Small Molecule Inhibitors for Histone Methyltransferases in Cancer
- Discovery and Optimization of Inhibitors of DNA Methyltransferase as Novel Drugs for Cancer Therapy
- Bifunctional Prokaryotic DNA-Methyltransferases
- Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
- A Histone Cycle
- DNA Methylation and Histone Deacetylation: Interplay and Combined Therapy in Cancer
- Free Histones and the Cell Cycle